Skip to content

Maris Kabul

Application submitted

Medicago sativa L. Alfalfa · Agricultural · bred by Plant Breeding International Cambridge Ltd (GB)

also searched as: марис кабул

Variety description

10 August 2026

The variety was developed with the participation of the wild relative Medicago hemicycla, which allowed the plant to be endowed with protective properties. The vegetation period from emergence to flowering is characterized as short.

The plant possesses resistance to Verticillium wilt caused by the pathogens Verticillium albo-atrum or V. alfalfae. The defense mechanism is based on the presence of a dominant gene that limits the spread of the pathogen in xylem tissues through a hypersensitive response. In studies, the variety is classified as moderately resistant.

The variety was used in agricultural production and served as important genetic material for breeding programs aimed at creating disease-resistant alfalfa lines.

Sources6
  • Loading…

Countries of admission

3 jurisdictions

Green indicates countries where the variety is listed in the national catalogue and its seeds are authorized for sale. Expired registrations are marked separately: the variety was previously admitted, but sale is no longer permitted.

terminated no record

Variety registered as early as 2 jurisdictions, data for which we do not publish: their registry licenses have not yet been verified. This section will be available upon verification.

Variety in registries Regions of admission, rights holders, and status of plant breeders' rights

Parties

Breeder
Plant Breeding International Cambridge Ltd (GB) 127 Developed the variety
Applicant
Nickerson RPB Ltd. (UK) Submitted the application to the register
Maintainer
PLANT BREEDING INTERNATIONAL CAMBRIDGE 789 Responsible for variety maintenance

Admission to trade

The variety is listed in the national registry — its seeds are authorized for sale in this country.

  • FR France Terminated

    № 0050541

    Registration
    1 January 1973
    Terminated
    1 January 1983
  • GB United Kingdom Terminated

    № 14/13

    Terminated
    1 October 1986
  • HR Croatia Terminated

    № 1004576

    Terminated
    16 November 2009
  • DK Denmark Active

    № 10586

    Application
    15 February 1973
    Terminated
    28 December 1978

Plant breeders' rights

The right is granted for a limited term: propagation of the variety requires a license from the rights holder.

United Kingdom № 14/13
Terminated
  1. Application filed
  2. Registered
  3. Entry closed 23 June 1986

More 1 record protections in other jurisdictions are shown on the map above.

Records are sourced from official registry publications. Data sources and legal status

Found an error in the record?

The directory replicates the primary source. If an entry differs from the official publication, please specify the discrepancy and provide a link if possible. Corrections are added to the moderation queue.

This is a directory, not an official registry: data is based on public disclosures and may have changed. More about sources

Same species

Other varieties: Alfalfa

All 1 053 varieties of species

Medicago sativa L. · Alfalfa

SCHMIDT-GAMBAZZA| Hedwig Schmidt-Gambazza

AT DE FR PL
11 records

Medicago sativa L. · Alfalfa

Institute of Field and Vegetable Crops (SB)

BG SI
11 records

Medicago sativa L. · Alfalfa

Instituto Nacional de Tecnologia Agropecuaria INTA

ES
10 records

Maricopa

Active

Medicago sativa L. · Alfalfa

PLANT GENETICS

ES
5 records

Marina

Active

Medicago sativa L. · Alfalfa

Tourneur Grandes Cultures Obtentions SNC (FR)

FR
7 records

Maris Phoenix

Application submitted

Medicago sativa L. · Alfalfa

Plant Breeding International Cambridge Ltd (GB)

FR HR
5 records

Nearby in the species list Malvina, Manon, Manto, Maraviglia, Marchigiana, Maremmana, Marenostrum, Margus, Maricopa, Marina, Maris Phoenix, Marja, Marshal, Marvelle, MATILDA, Matteus, Maxima, Maya, Mayaco, Mazurka

Discussion: Maris Kabul

0 messages

Growing experience and notes on the entry. Comments are not part of the reference data and are not verified against primary sources.

Comments are open to signed-in readers. Sign in · Sign up